Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-01-07

FDA Approved: JINTELI — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for JINTELI, providing approval related to its norethindrone acetate and ethinyl estradiol formulation from Teva Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • JINTELI (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for JINTELI (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)